IBM rebounded to $214: revenue grew only 1%. Is this rally really about AI, or about cash flow?
Let’s start with the surface.
On July 24, the latest trading day, $IBM U.S. spot shares opened at $208.96, hit a high of $216.07, a low of $207.01, and closed at $214.07, up 3.63% from the previous close of $206.58. Alpaca IEX showed volume of 409,000 shares, below the roughly 797,000-share average over the past 10 trading days, which suggests the rebound is real, but not yet a volume-backed breakout.
As of 10:58 Beijing time on July 25, Binance IBMUSDT TradFi perpetuals were quoted at 212.60 USDT, up 3.44% over the rolling 24 hours. The contract still has its own funding rate and trading hours, so you can’t simply mix it up with the NYSE closing price as if they were the same number.
What matters most in IBM’s earnings report is not total revenue, but the revenue mix.
Second-quarter revenue was $17.2 billion, up just 1% year over year, which on the surface is far from dazzling. But software revenue was $7.8 billion, up 5%; within that, Red Hat grew 11% and the Data segment grew 19%. By contrast, consulting revenue was basically flat, infrastructure revenue fell 7%, IBM Z plunged 42%, while distributed infrastructure rose 37%.
In plain English: the old IBM still has a clear hardware cycle, but the new IBM is increasingly making money from software, hybrid cloud, and data tools. Software is more subscription-based and renewal-driven, so revenue visibility is higher; mainframes, on the other hand, are driven by new-product cycles, which can sell strongly this year and then naturally cool off next year. So you can’t value the entire company just because it is called an “AI company”; what really determines quality is whether software growth can offset mainframe volatility.
The second key point is profit and cash flow. The company generated $2.5 billion in free cash flow in the second quarter and $4.8 billion in the first half, and it raised its full-year constant-currency revenue growth outlook to 4%–5%, while still expecting full-year free cash flow to increase by about $1 billion year over year. That is the core reason the stock is willing to rebound: total revenue is not growing fast, but management says margins and cash conversion will keep improving.
The third key point is the post-acquisition balance sheet. IBM has invested $10.5 billion in acquisitions so far this year, ended the quarter with $8.2 billion in cash and marketable securities, and has total debt of $62.0 billion. Acquisitions can help fill out AI, automation, and data capabilities, but they also bring integration, amortization, and debt pressure. The next phase is not just about what was bought; it is about whether incremental software revenue and cash flow can cover the bill.
From a positioning standpoint, $207–210 is the first support zone; if that fails, look to $199–202. On the upside, $216–220 is the near-term resistance zone, and only a break above it would justify talking about a larger recovery.
In the short term, watch whether $216 can break out on volume; for the swing trade, focus on software growth and a rebound in consulting; for the long term, there is only one thing that matters: whether acquisitions can be turned into repeatable free cash flow.
Would you rather think of IBM now as a steady-cash-flow software company, or still as a cyclical hardware company?
$IBM #美股 #AI软件 #TradFi
Let’s start with the surface.
On July 24, the latest trading day, $IBM U.S. spot shares opened at $208.96, hit a high of $216.07, a low of $207.01, and closed at $214.07, up 3.63% from the previous close of $206.58. Alpaca IEX showed volume of 409,000 shares, below the roughly 797,000-share average over the past 10 trading days, which suggests the rebound is real, but not yet a volume-backed breakout.
As of 10:58 Beijing time on July 25, Binance IBMUSDT TradFi perpetuals were quoted at 212.60 USDT, up 3.44% over the rolling 24 hours. The contract still has its own funding rate and trading hours, so you can’t simply mix it up with the NYSE closing price as if they were the same number.
What matters most in IBM’s earnings report is not total revenue, but the revenue mix.
Second-quarter revenue was $17.2 billion, up just 1% year over year, which on the surface is far from dazzling. But software revenue was $7.8 billion, up 5%; within that, Red Hat grew 11% and the Data segment grew 19%. By contrast, consulting revenue was basically flat, infrastructure revenue fell 7%, IBM Z plunged 42%, while distributed infrastructure rose 37%.
In plain English: the old IBM still has a clear hardware cycle, but the new IBM is increasingly making money from software, hybrid cloud, and data tools. Software is more subscription-based and renewal-driven, so revenue visibility is higher; mainframes, on the other hand, are driven by new-product cycles, which can sell strongly this year and then naturally cool off next year. So you can’t value the entire company just because it is called an “AI company”; what really determines quality is whether software growth can offset mainframe volatility.
The second key point is profit and cash flow. The company generated $2.5 billion in free cash flow in the second quarter and $4.8 billion in the first half, and it raised its full-year constant-currency revenue growth outlook to 4%–5%, while still expecting full-year free cash flow to increase by about $1 billion year over year. That is the core reason the stock is willing to rebound: total revenue is not growing fast, but management says margins and cash conversion will keep improving.
The third key point is the post-acquisition balance sheet. IBM has invested $10.5 billion in acquisitions so far this year, ended the quarter with $8.2 billion in cash and marketable securities, and has total debt of $62.0 billion. Acquisitions can help fill out AI, automation, and data capabilities, but they also bring integration, amortization, and debt pressure. The next phase is not just about what was bought; it is about whether incremental software revenue and cash flow can cover the bill.
From a positioning standpoint, $207–210 is the first support zone; if that fails, look to $199–202. On the upside, $216–220 is the near-term resistance zone, and only a break above it would justify talking about a larger recovery.
In the short term, watch whether $216 can break out on volume; for the swing trade, focus on software growth and a rebound in consulting; for the long term, there is only one thing that matters: whether acquisitions can be turned into repeatable free cash flow.
Would you rather think of IBM now as a steady-cash-flow software company, or still as a cyclical hardware company?
$IBM #美股 #AI软件 #TradFi